During the past decade, Illinois CancerCare-Pekin conducted 205 clinical trials. In the 10-year time frame, 205 clinical trials started and 210 clinical trials were completed, i.e. on average, 102.4% percent of trials that started reached the finish line to date. In the past 5 years, 98 clinical trials started and 93 clinical trials were completed. i.e. 94.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Illinois CancerCare-Pekin" #1 sponsor was "National Cancer Institute (NCI)" with 165 trials, followed by "Alliance for Clinical Trials in Oncology" with 124 trials sponsored, "SWOG Cancer Research Network" with 63 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 30 trials sponsored and "Eastern Cooperative Oncology Group" with 30 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois CancerCare-Pekin" #1 collaborator was "National Cancer Institute (NCI)" with 284 trials as a collaborator, "NRG Oncology" with 37 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator, "NCIC Clinical Trials Group" with 13 trials as a collaborator and "Canadian Cancer Trials Group" with 12 trials as a collaborator. Other collaborators include 76 different institutions and companies that were collaborators in the rest 47 trials.

According to Clinical.Site data, the most researched conditions in "Illinois CancerCare-Pekin" are "Breast Cancer" (41 trials), "Lung Cancer" (21 trials), "Lymphoma" (20 trials), "Colorectal Cancer" (11 trials) and "Leukemia" (11 trials). Many other conditions were trialed in "Illinois CancerCare-Pekin" in a lesser frequency.

Most popular intervention types in "Illinois CancerCare-Pekin" are "Drug" (364 trials), "Other" (236 trials), "Biological" (173 trials), "Procedure" (93 trials) and "Radiation" (76 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (96 trials), "Quality-of-Life Assessment" (82 trials), "Questionnaire Administration" (56 trials), "Computed Tomography" (42 trials) and "Biospecimen Collection" (40 trials). Other intervention names were less common.

The vast majority of trials in "Illinois CancerCare-Pekin" are 366 trials for "All" genders, 71 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "Illinois CancerCare-Pekin". undefined are not yet recruiting, 91 are recruiting, 144 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 182 completed trials in Illinois CancerCare-Pekin, 9 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Illinois CancerCare-Pekin, 23 "Phase 1" clinical trials were conducted, 226 "Phase 2" clinical trials and 212 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".